OverviewSuggest Edit
Zymergen is a company that researches, develops and manufactures microbes for industrial application. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues either inside the body or on the skin to close a wound or to protect against infection. The company also integrates artificial intelligence algorithms and robotic genomic to search the microbial genome, discover new materials, commercialize new products and improve existing bio-manufactured products.
| Type | Private | |
| Founded | 2013 | |
| HQ | Emeryville, CA, US | Map |
| Website | zymergen.com | |
| Employee Ratings | More | |
| Overall Culture | F | More |
Recent NewsAll News
- Zymergen Reports Preliminary First Quarter 2021 Financial Results
- Zymergen to Present at UBS Global Healthcare Virtual Conference
- Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021
- Zymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Key People/Management at Zymergen
Josh Hoffman
Chief Executive Officer and Co-Founder, Director
Judy Gilbert
Chief People Officer
Jack Gold
Chief Marketing Officer
Mina Kim
Chief Legal Officer
Aaron Kimball
Chief Technology Officer
Zach Serber
Chief Science Officer and Co-Founder
Zymergen Office Locations
Zymergen has offices in Emeryville, Boise, Seattle and 千代田区
Emeryville, CA, US (HQ)
5980 Horton St #105
Boise, ID, US
12426 W Explorer Dr #250
Seattle, WA, US
1624 4th Ave #300
千代田区, JP
4/F East Tower 1-5-1 Otemachi First Square
Zymergen Financials and Metrics
Summary Metrics
Founding Date | 2013 |
Zymergen total Funding | $876.1 m |
Zymergen latest funding size | $300 m |
Time since last funding | 9 months ago |
Zymergen investors | Goldman Sachs, Innovation Endeavors, True Ventures, SoftBank Capital, LLC, Threshold, Data Collective, AME Cloud Ventures, Two Sigma Ventures, Iconiq Capital, Baillie Gifford, Obvious Ventures, Prelude Ventures, Perceptive Advisors, Tao Capital Partners, Linden Mobile Ventures, Two Sigma Investments, Scifi VC, SoftBank Vision Fund, Data Collective DCVC, Hanwha Asset Management, Genoa Ventures, Baron Capital Group |
Zymergen's latest funding round in September 2020 was reported to be $300 m. In total, Zymergen has raised $876.1 m
Zymergen Revenue
Zymergen's revenue was reported to be $13.28 m in FY, 2020 which is a 13.8% decrease from the previous period.
| USD | |
|---|---|
Revenue (FY, 2020) | 13.3m |
Revenue growth (FY, 2019 - FY, 2020), % | (13.8%) |
Gross profit (FY, 2020) | (71.5m) |
Gross profit margin (FY, 2020), % | (538.5%) |
Net income (FY, 2020) | (262.2m) |
EBIT (FY, 2020) | 241.1m |
Cash (31-Dec-2020) | 210.2m |
| USD | FY, 2019 |
|---|---|
Revenue/Employee | 22.1k |
Debt/Equity | -0.2 x |
Debt/Assets | 0.4 x |
Financial Leverage | -0.5 x |
Zymergen Operating Metrics
Show all operating metricsZymergen Acquisitions / Subsidiaries
| Company Name | Date | Deal Size |
|---|---|---|
| enEvolv | March 19, 2020 | |
| Radiant Genomics | January 08, 2018 |
Zymergen Revenue Breakdown
Zymergen revenue breakdown by geographic segment: 45.9% from United States of America, 35.7% from Asia and 18.4% from Europe
Zymergen Cybersecurity Score
Zymergen Online and Social Media Presence
7.79k Twitter followers
Zymergen has 7.79k Twitter Followers. The number of followers has increased 4.5% month over month and increased 35.7% quarter over quarter
Zymergen's Trends
Twitter Engagement Stats for @Zymergen
442
Tweets
556
Following
7.8k
Followers
8
Tweets last 30 days
13.3
Avg. likes per Tweet
87.5%
Tweets with engagement
Zymergen Company Culture
Overall Culture
F
49/100
CEO Rating
F
53/100
Compensation
C+
69/100
Zymergen News and Updates
May 24, 2021
Zymergen Reports Preliminary First Quarter 2021 Financial Results
EMERYVILLE, Calif., May 24, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s leading biofacturing companies, today reported preliminary financial results for the first quarter ended March 31, 2021.
May 21, 2021
Zymergen to Present at UBS Global Healthcare Virtual Conference
EMERYVILLE, Calif., May 21, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen today announced the company will be participating in the upcoming UBS Global Healthcare Virtual Conference.
May 13, 2021
Zymergen to Report First Quarter 2021 Financial Results on May 24, 2021
EMERYVILLE, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Biofacturing leader Zymergen, today announced it will report financial results for the first quarter 2021 after market close on Monday, May 24th, 2021. The company’s management will host a conference call beginning at 1:30 p.m. Pacific Time / 4:…
April 26, 2021
Zymergen Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
EMERYVILLE, Calif., April 26, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced the closing of its initial public offering of 18,549,500 shares of its common stock, including the full exercise by the underwriters of their optio…
April 22, 2021
In An Earth Day Test For Synthetic Biology Field, Zymergen Raises $500 Million In IPO
"I love the symbolism that we're going public on Earth Day," says Zymergen's Josh Hoffman. The synthetic biology company raised $500 million in an IPO set to value the company at more than $3 billion.
April 22, 2021
Zymergen Announces Pricing of Upsized Initial Public Offering
EMERYVILLE, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- Zymergen Inc. (“Zymergen”), one of the world’s foremost biofacturing companies, today announced the pricing of its initial public offering of 16,130,000 shares of its common stock at a public offering price of $31.00 per share. In addition, Zy…
Zymergen Blogs
June 14, 2021
How machine learning is changing the way we design products
Marian Farah’s team is honing in on better chemicals and materials — without the AI hype.
The post How machine learning is changing the way we design products appeared first on Zymergen.
June 03, 2021
Bridging labs and software: A day in the life of a tech manager at Zymergen
As part of our We Make Tomorrow conversation series, Sheeva Haghighat shares how she builds digital solutions for biological problems.
The post Bridging labs and software: A day in the life of a tech manager at Zymergen appeared first on Zymergen.
May 26, 2021
We Make Tomorrow: On becoming a biological data scientist
"I love that data science brings together people who are super motivated" reflects Senior Data Scientist Janet Matsen
The post We Make Tomorrow: On becoming a biological data scientist appeared first on Zymergen.
May 21, 2021
At the intersection of technology and finance: In conversation with Christine Gorjanc
We sat down with newly appointed board member Christine Gorjanc to learn more about her career at the intersection of technology and finance, and her plans to help realize our company vision.
The post At the intersection of technology and finance: In conversation with Christine Gorjanc appeared firs…
May 12, 2021
Digital screens of the future: Touch Taiwan 2021 in pictures
A visual tour of the materials and innovations going into your next digital device, featuring Hyaline Z2 and clear touch panel displays.
The post Digital screens of the future: Touch Taiwan 2021 in pictures appeared first on Zymergen.
May 10, 2021
Scratching the surface of what’s possible with biology
Zymergen VP of Operations Jed Dean offers his perspective on using biology to scale discoveries into global solutions
The post Scratching the surface of what’s possible with biology appeared first on Zymergen.
Zymergen Frequently Asked Questions
When was Zymergen founded?
Zymergen was founded in 2013.
Who are Zymergen key executives?
Zymergen's key executives are Josh Hoffman, Judy Gilbert and Jack Gold.
How many employees does Zymergen have?
Zymergen has 798 employees.
What is Zymergen revenue?
Latest Zymergen annual revenue is $13.3 m.
What is Zymergen revenue per employee?
Latest Zymergen revenue per employee is $16.6 k.
Who are Zymergen competitors?
Competitors of Zymergen include Biodesix, Ischemia Care and Scailyte.
Where is Zymergen headquarters?
Zymergen headquarters is located at 5980 Horton St #105, Emeryville.
Where are Zymergen offices?
Zymergen has offices in Emeryville, Boise, Seattle and 千代田区.
How many offices does Zymergen have?
Zymergen has 5 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies